                               SEQUENCE LISTING

<110> TOBEBIO NOVEL DRUG LABORATORY CO., LTD.
 
<120> SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING 
      CANCER

<130> 36380-44465/WO (001WO)

<140> PCT/US2020/055180
<141> 2020-10-11

<150> 62/914,174
<151> 2019-10-11

<160> 20    

<170> PatentIn version 3.5

<210> 1
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
His Gly Val Ser Gly His Gly Gln His Gly Val His Gly 
1               5                   10              


<210> 2
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Val Ser Gly His Gly Gln His Gly Val His Gly 
1               5                   10          


<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Val Ser Gly His Gly Gln His Gly Val His 
1               5                   10  


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Ser Gly His Gly Gln His Gly Val 
1               5               


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Pro Ser Leu Thr Gly His Gly Phe His Gly Val Tyr Asp 
1               5                   10              


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Phe Ile Val Ser Ala His Gly Asp His Gly Val 
1               5                   10      


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Thr His Gly Gln His Gly Val 
1               5           


<210> 8
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
His Gly His Gly Val His Gly 
1               5           


<210> 9
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Leu Ala Ser Leu His Gly Gln His Gly Val 
1               5                   10  


<210> 10
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Cys Val Val Thr Gly His Gly Ser His Gly Val Phe Val 
1               5                   10              


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Ile Ser Gly His Gly Gln His Gly Val Pro 
1               5                   10  


<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Cys Gly His Gly Asn His Gly Val His 
1               5                   


<210> 13
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Ile Val Ala Arg Ile His Gly Gln Asn His Gly Val 
1               5                   10          


<210> 14
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
His Gly Ser Asp Gly His Gly Val Gln His Gly 
1               5                   10      


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Phe Gly His Gly His Gly Val 
1               5           


<210> 16
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
His Gly Asn His Gly Val Leu Ala 
1               5               


<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
His Gly Asp Ser Gly His Gly Gln His Gly Val Asp 
1               5                   10          


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
His Gly His Gly Val Pro Leu 
1               5           


<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Ser Gly His Gly Ala Val His Gly Val Met 
1               5                   10  


<210> 20
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Tyr Ala Met Ser Gly His Gly His Gly Val Phe Ile 
1               5                   10          


